This market research report includes a detailed segmentation of the solid tumor testing market in the US by technology (conventional testing and genetic testing) and by cancer types (breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer and other). The leading vendors analyzed in this report are Abbott Molecular, Dako, Beckman Coulter and Roche Diagnostics.
Technavio’s market research analysts estimate the solid tumor testing market in the US, to grow at a CAGR of 11% between 2016 and 2020. Solid tumor testing or screening is an effective process of identifying cancer at an early stage to avoid spreading of cancerous cells throughout the body. Increase in healthcare coverage reforms and rise in genetic testing among end-users have propelled the demand for solid tumor testing in the US. The market is witnessing the penetration of advanced products for cancer diagnosis and approval of many novel test kits.
The new market research report from Technavio provides a breakdown and analysis of the solid tumor testing segments by technology.
“Increased use if mass spectrometry is one of the latest trends in the solid tumor testing market. One of the major advantages of this technology is that it can give accurate results with the minimal quantity of sample and does not even require specially purified samples. Of late, Advion and Thermo Fisher Scientific have launched bench-top mass spectrometers, which are fully automated and provide immediate results by sample analysis,” says Brahadeesh Chandrasekaran, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Conventional testing segment dominates the solid tumor testing market, occupying around 66% of the total market share. Conventional testing for solid tumors primarily includes mutation tests that study mutation analysis or genetic alterations in the cancerous cells. Some of the common conventional tests for solid tumors are UniCel DxL 600 and UniCel DxL 800.
The key vendors in the solid tumor testing market in the US are Abbott Molecular, Dako, Beckman Coulter and Roche Diagnostics. Intense competition prevails in this market because of the presence of many small and medium-sized vendors in the US. Vendors in this market are focusing on on expanding their market penetration by launching innovative products, particularly POC cancer testing kits.
A more detailed analysis is available in the Technavio report, Solid Tumor Testing Market in the US 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
